Viewing Study NCT02275416


Ignite Creation Date: 2025-12-26 @ 11:48 AM
Ignite Modification Date: 2025-12-26 @ 11:48 AM
Study NCT ID: NCT02275416
Status: COMPLETED
Last Update Posted: 2024-12-16
First Post: 2014-09-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
Sponsor: Ultimovacs ASA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-02-02
Start Date Type: ACTUAL
Primary Completion Date: 2016-10-06
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-03
Completion Date Type: ACTUAL
First Submit Date: 2014-09-12
First Submit QC Date: None
Study First Post Date: 2014-10-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-12-11
Last Update Post Date: 2024-12-16
Last Update Post Date Type: ACTUAL